The global veterinary endotracheal tubes market size is expected to reach USD 15.4 million by 2030, registering a CAGR of 8.3% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is driven by an increasing pet population undergoing surgical procedures, coupled with healthcare expenditure, pet insurance, and a growing number of veterinary facilities. For instance, in 2022 according to the global animal health association, there will be around 1 billion or more pets worldwide and pet ownership will increase rapidly all around the world.
The COVID-19 pandemic impacted the market notably. This included disruption in the supply chain, reduced access to veterinary services, impact on trade and exports, and economic constraints on farmers. The manufacturing of veterinary products also was hampered due to a lack of proper materials for both equipment and disposables. However, during COVID-19, there was a high number of pet adoption rate, and hence post COVID-19, most of the pet owner visited hospitals to get their pets treated and tested, which included the usage of endotracheal tubes for carrying out some major surgeries that required general anesthesia.
Rising healthcare expenditure towards pets drives the adoption of veterinary endotracheal tubes, as most of the pet owners are concerned about their pets and do not mind spending high amounts to get their pets treated. During emergencies, pet owners rely on hospitals to get their pets treated, and in such situations, endotracheal tubes are used to keep the pet stable during surgeries or emergency situations thereby elevating the use of veterinary endotracheal tubes.
Request a free sample copy or view report summary: Veterinary Endotracheal Tubes Market Report
Based on animal type, the dog segment dominated the market in 2022 with a revenue share of 41%. The cats segment is projected to grow at the fastest CAGR of about 9% over the forecast period
Based on product type, the cuffed type segment attributed to the largest share of over 65% in 2022. The uncuffed segment on the other hand is anticipated to grow at the fastest CAGR of over 9% over the forecast period
In 2022, in terms of end-use, the hospitals segment held the largest revenue share of around 61%. The clinics segment is anticipated to grow at the fastest CAGR of over 8% during the forecast period
In 2022, North America held the largest regional share of more than 31% of the market. Asia Pacific is anticipated to grow at the fastest CAGR of about 9.1% owing to the thriving veterinary hospital sector in key markets
Grand View Research has segmented the global veterinary endotracheal tubes market based on animal type, product type, end-use, and region:
Veterinary Endotracheal Tubes Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
Dog
Cats
Others
Veterinary Endotracheal Tubes Product Type Outlook (Revenue, USD Million, 2018 - 2030)
Cuffed
Uncuffed
Veterinary Endotracheal Tubes End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Clinics
Veterinary Endotracheal Tubes Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Netherlands
Rest of Europe
Asia Pacific
Japan
China
India
South Korea
Australia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Middle East & Africa
South Africa
Rest of MEA
List of Key Players in the Veterinary Endotracheal Tubes Market
Medtronic
Conduct Science
Harvard Apparatus
RWD Life Science Co., LTD
Vetamac, Inc.
"The quality of research they have done for us has been excellent..."